Viewing Study NCT06542133


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-01-07 @ 3:29 AM
Study NCT ID: NCT06542133
Status: COMPLETED
Last Update Posted: 2025-04-10
First Post: 2024-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AVEIR Remote Care System Non-Significant Risk Study
Sponsor: Abbott Medical Devices
Organization:

Study Overview

Official Title: AVEIR Remote Care System Data Collection Non-Significant Risk Study
Status: COMPLETED
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of the study is to understand the performance of the AVEIR Remote Care System in an initial patient cohort which will inform the ability to offer a remote follow-up solution to all patients implanted with Aveir LP devices.
Detailed Description: To collect acute performance data about the AVEIR Remote Care System in participants implanted with a compatible dual or single chamber Aveir Leadless Pacemaker System by participants completing remote transmissions with the system

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: